Key result
Additional linear ablation from the superior vena cava to the right atrial septum after CPVI reduced atrial fibrillation recurrence compared to CPVI alone.
Why the study?
Does additional linear ablation from the superior vena cava to the right atrial septum after pulmonary vein isolation reduce recurrence in patients with paroxysmal atrial fibrillation?
RCT (n=200)
randomly assigned
Does additional linear ablation from the superior vena cava to the right atrial septum after pulmonary vein isolation reduce recurrence in patients with paroxysmal atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Additional linear ablation from the superior vena cava to the right atrial septum after pulmonary vein isolation significantly reduces the recurrence of paroxysmal atrial fibrillation, despite a longer procedure time.
AIMS: Although circumferential pulmonary vein isolation (CPVI) has been considered as the cornerstone for paroxysmal atrial fibrillation (PAF) ablation, there has been a substantial recurrence rate. We conducted a prospectively randomized study to evaluate whether additional linear ablation from the superior vena cava (SVC) to the right atrial (RA) septum (SVC-L) improves the clinical outcome. METHODS AND RESULTS: This study enroled 200 patients with PAF (male 74.5%, 56.8 ± 11.7 years old) randomly assigned to either the CPVI (n = 100) or CPVI + SVC-L (n = 100) groups. An RA isthmus ablation was performed in all patients. The CPVI + SVC-L group required a longer ablation procedure time (82.7 ± 17.9 min) than the CPVI group (63.6 ± 16.8 min, P < 0.001). The complication rates were 5% in CPVI + SVC-L group and 2% in CPVI group, respectively (P = 0.445). Two CPVI + SVC-L group patients had post-procedural sinus node dysfunction, which recovered within 24 h. During 12.2 ± 5.3 months of follow-up, the recurrence rate was significantly lower in the CPVI + SVC-L group (6%) than the CPVI group (27%, P < 0.001). The post-procedural 3-month follow-up heart rate variability in the CPVI + SVC-L group showed a significantly greater reduction in the rMSSD (25.2 ± 13.7 vs. 13.7 ± 8.5 ms, P < 0.001), HF (10.2 ± 7.1 vs. 5.5 ± 5.8 ms(2), P < 0.001), and LF/HF (1.6 ± 0.5 vs. 0.9 ± 0.3, P < 0.001) than in the CPVI group. CONCLUSION: In spite of a longer procedure time and risk of transient sinus node dysfunction, an SVC-L in addition to CPVI improved the clinical outcome of catheter ablation, and was associated with post-procedural autonomic neural remodelling in patients with PAF.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2014) conducted an RCT in paroxysmal atrial fibrillation (n=200). Circumferential pulmonary vein isolation (CPVI) + additional linear ablation from superior vena cava to right atrial septum (SVC-L) vs. CPVI alone was evaluated on Recurrence rate (p=<0.001). Additional linear ablation from the superior vena cava to the right atrial septum after CPVI reduced atrial fibrillation recurrence compared to CPVI alone.
Synapse has enriched 10 related papers. Consider them for comparative context: